Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Sponsor
AIDS Clinical Trials Group (Other)
Overall Status
Completed
CT.gov ID
NCT00001137
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
5,982
77
166
77.7
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A compilation of outcomes of various antiretroviral therapies would be beneficial when evaluating which strategies are most effective in long-term treatment of HIV-1. Using data from present and recently completed studies, this study will collect information on therapies and their control of HIV infection and maintenance of durable suppression of HIV-1 replication.

    No treatment is provided by this study, but patients will continue to receive highly active antiretroviral therapy (HAART) from other studies in which they are coenrolled. Blood and urine collection will occur at study entry and periodically throughout the study. Women may undergo pelvic exams and Pap smears. Portions of blood samples will be stored to evaluate genotypic/phenotypic susceptibility testing. Medical histories, physical exams, and questionnaires will be completed periodically.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    5982 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Protocol
    Study Start Date :
    Jan 1, 2000
    Actual Primary Completion Date :
    Nov 1, 2013
    Actual Study Completion Date :
    Nov 1, 2013

    Outcome Measures

    Primary Outcome Measures

    1. Successive suppressed viral load measures [Measured 144 weeks after randomization]

    2. Genotypic or phenotypic resistance [Measured at baseline and study completion]

    3. Complications of HIV disease, including survival, HIV-related opportunistic infections, HIV-related non-opportunistic complications, adverse effects of antiretroviral therapies of grade three or greater [Measured throughout]

    4. Absolute number and percentage of CD4 and CD8 T cells [Measured 144 weeks after randomization]

    5. Absolute number and percentage of naive cells, including CD4, CD45RA, and CD62L cells [Measured 144 weeks after randomization]

    6. Absolute number and percentage of memory cells, including CD4, CD45RO+, and CD45RA- cells [Measured 144 weeks after randomization]

    7. Levels of immune activation markers, including CD8, CD38, and HLA-DR cells [Measured 144 weeks after randomization]

    Secondary Outcome Measures

    1. HIV-1 latency or replication in tissue or cellular reservoirs [Measured at baseline, Week 16, Week 48, and study completion]

    2. Syncytium and non-syncytium inducing (SI/NSI) phenotype [Measured at baseline, Week 16, Week 48, and study completion]

    3. Metabolic and neurologic complications [Measured at baseline, Week 16, Week 48, and study completion]

    4. Immune responses to antigens such as cytomegalovirus (CMV), Myobacterium avium complex (MAC), Candida, and HIV [Measured 144 weeks after randomization]

    5. Plasma concentrations of antiretroviral medications other than nucleoside/tide reverse transcriptase inhibitors (NRTIs) [Measured at baseline, Week 16, and study completion]

    6. Effect of gender, use of hormonal therapies, presence or absence of menopause on short- and long-term virologic suppression, and pap smear abnormalities [Measured at baseline, Week 48, and study completion]

    7. Quality of life scores [Measured at baseline, Week 48, and study completion]

    8. Subject-reported patterns of adherence [Measured at baseline, Week 48, and study completion]

    9. Estimated inpatient, outpatient, and total costs [Measured at study completion]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria

    • HIV-1 infected

    • Enrolled in an AIDS Clinical Trial Group (ACTG) parent study and has enrolled in this study on or before the Week 16 visit of the parent study, including the visit window of the parent study. More information on this criterion can be found in the protocol.

    • Willing to provide consent for the release and use of clinical data from the parent study

    • Life expectancy of at least 24 weeks

    • Parent or guardian willing to provide informed consent, if applicable

    Exclusion Criteria

    • Active alcohol or drug abuse that may interfere with the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Univ of Alabama at Birmingham Birmingham Alabama United States 35294
    2 Kaiser Permanente LAMC Los Angeles California United States 90027
    3 Univ of Southern California / LA County USC Med Ctr Los Angeles California United States 900331079
    4 UCLA CARE Ctr Los Angeles California United States 90095
    5 Willow Clinic Menlo Park California United States 94025
    6 UC Davis Med Ctr Sacramento California United States 95814
    7 Univ of California / San Diego Treatment Ctr San Diego California United States 921036325
    8 Univ of California, San Francisco/San Francisco General Hosp San Francisco California United States 94110
    9 Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium San Jose California United States 951282699
    10 Marin County Specialty Clinic San Rafael California United States 94903
    11 San Mateo AIDS Program / Stanford Univ Stanford California United States 943055107
    12 Stanford Univ Med Ctr Stanford California United States 943055107
    13 Harbor UCLA Med Ctr Torrance California United States 90502
    14 Denver Public Health CRS Denver Colorado United States 80204
    15 Univ of Colorado Health Sciences Ctr Denver Colorado United States 80262
    16 Georgetown Univ Med Ctr Washington District of Columbia United States 20007
    17 Univ of Miami School of Medicine Miami Florida United States 331361013
    18 Emory Univ Atlanta Georgia United States 30308
    19 Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr Atlanta Georgia United States 303652225
    20 Univ of Hawaii Honolulu Hawaii United States 96816
    21 Tripler Army Med Ctr Tripler AMC Hawaii United States 96859
    22 Northwestern Univ Med School Chicago Illinois United States 60611
    23 Cook County Hosp Chicago Illinois United States 60612
    24 Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois United States 60612
    25 Indiana Univ Hosp Indianapolis Indiana United States 462025250
    26 Division of Inf Diseases/ Indiana Univ Hosp Indianapolis Indiana United States 46202
    27 Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana United States 46202
    28 Univ of Iowa Hosp and Clinic Iowa City Iowa United States 52242
    29 Tulane Med Ctr Hosp New Orleans Louisiana United States 70112
    30 IHV Baltimore Treatment CRS Baltimore Maryland United States 21201
    31 Johns Hopkins Hosp Baltimore Maryland United States 21287
    32 Harvard (Massachusetts Gen Hosp) Boston Massachusetts United States 02114
    33 Brigham and Women's Hosp Boston Massachusetts United States 02115
    34 Boston Med Ctr Boston Massachusetts United States 02118
    35 Beth Israel Deaconess - West Campus Boston Massachusetts United States 02215
    36 Wayne State Univ. CRS Detroit Michigan United States 48201
    37 Hennepin County Medical Clinic Minneapolis Minnesota United States 55415
    38 Univ of Minnesota Minneapolis Minnesota United States 55455
    39 St Louis Regional Hosp / St Louis Regional Med Ctr St Louis Missouri United States 63112
    40 Univ of Nebraska Med Ctr Omaha Nebraska United States 681985130
    41 Cooper Univ. Hosp. CRS Camden New Jersey United States 08103
    42 New Jersey Medical School- Adult Clinical Research Ctr. CRS Newark New Jersey United States 07103
    43 Bronx-Lebanon Hosp. Ctr. CRS Bronx New York United States 10457
    44 SUNY / Erie County Med Ctr at Buffalo Buffalo New York United States 14215
    45 Beth Israel Med Ctr New York New York United States 10003
    46 Bellevue Hosp / New York Univ Med Ctr New York New York United States 10016
    47 NY Univ. HIV/AIDS CRS New York New York United States 10016
    48 Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ New York New York United States 10021
    49 Chelsea Ctr New York New York United States 10021
    50 Cornell Univ Med Ctr New York New York United States 10021
    51 Mount Sinai Med Ctr New York New York United States 10029
    52 Columbia Presbyterian Med Ctr New York New York United States 10032
    53 AIDS Care CRS Rochester, New York United States 14607
    54 Community Health Network Inc Rochester New York United States 14642
    55 Univ of Rochester Medical Center Rochester New York United States 14642
    56 Wake County Department of Health Chapel Hill North Carolina United States 27514
    57 Univ of North Carolina Chapel Hill North Carolina United States 275997215
    58 Carolinas Med Ctr Charlotte North Carolina United States 28203
    59 Duke Univ Med Ctr Durham North Carolina United States 27710
    60 Moses H Cone Memorial Hosp Greensboro North Carolina United States 27401
    61 Univ of Cincinnati Cincinnati Ohio United States 452670405
    62 Cleveland Clinic Cleveland Ohio United States 44106-5083
    63 MetroHealth Med Ctr Cleveland Ohio United States 441091998
    64 Ohio State Univ Hosp Clinic Columbus Ohio United States 432101228
    65 The Research & Education Group-Portland CRS Portland Oregon United States 97210
    66 Presbyterian Medical Center - Univ. of PA Norristown Pennsylvania United States 19401
    67 Univ of Pennsylvania at Philadelphia Philadelphia Pennsylvania United States 19104
    68 Univ of Pittsburgh Pittsburgh Pennsylvania United States 15213
    69 Julio Arroyo West Columbia South Carolina United States 29169
    70 Vanderbilt Univ Med Ctr Nashville Tennessee United States 37203
    71 Peabody Health Center CRS Dallas Texas United States 75215
    72 Univ of Texas, Southwestern Med Ctr of Dallas Dallas Texas United States 75390
    73 Houston AIDS Research Team CRS Houston Texas United States 77030
    74 Virginia Commonwealth Univ. Medical Ctr. CRS Richmond Virginia United States 23219
    75 Univ of Washington Seattle Washington United States 98104
    76 Puerto Rico-AIDS CRS San Juan, Puerto Rico 00935
    77 Univ of Puerto Rico San Juan Puerto Rico 009365067

    Sponsors and Collaborators

    • AIDS Clinical Trials Group
    • National Institute of Allergy and Infectious Diseases (NIAID)

    Investigators

    • Study Chair: Constance A. Benson, MD, Division of Infectious Disease, Antiviral Research Center, University of California, San Diego
    • Study Chair: Ann C. Collier, MD, University of Washington

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    AIDS Clinical Trials Group
    ClinicalTrials.gov Identifier:
    NCT00001137
    Other Study ID Numbers:
    • ACTG A5001
    • 1U01AI068636
    • AACTG A5001
    First Posted:
    Aug 31, 2001
    Last Update Posted:
    Dec 6, 2013
    Last Verified:
    Dec 1, 2013

    Study Results

    No Results Posted as of Dec 6, 2013